Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors

Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors

Yolanda Piña,1 Samuel K Houston,1 Timothy G Murray,1 Tulay Koru-Sengul,2,3 Christina Decatur,1 William K Scott,4 Lubov Nathanson,4 Jennifer Clarke,2 Theodore J Lampidis,51Bascom Palmer Eye Institute, 2Department of Epidemiology and Public Health, 3Sylvester Comprehensive Cancer Center...

Full description

Bibliographic Details
Main Authors: Piña Y, Houston SK, Murray TG, Koru-Sengul T, Decatur C, Scott WK, Nathanson L, Clarke J, Lampidis TJ
Format: Article
Language:English
Published: Dove Medical Press 2012-05-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/retinoblastoma-treatment-impact-of-the-glycolytic-inhibitor-2-deoxy-d--a9995

Internet

http://www.dovepress.com/retinoblastoma-treatment-impact-of-the-glycolytic-inhibitor-2-deoxy-d--a9995

Similar Items